Prime Medicine
Edit info- Founded: 2021
- Location: Cambridge, MA
- Employee range: 50 - 200
- Clinical stage: Clin0
- Therapy area: chronic granulomatous disease
- Drug types: GEN
- Lead product: PM359
- Funding: $175M IPO Oct 2022; $315M A Jul 2021
primemedicine.com linkedin.com job board
About:
Prime Medicine is using the latest CRISPR technology to bring gene editing to patients. Prime editing is an innovative new approach to achieve precision genome editing without inducing double-stranded breaks. This enables safer and more efficient editing and has the potential to address more than 90% of known disease-causing mutations. Prime Medicine is using this “search and replace” tool to restore normal genetic function to almost anywhere in the genome. To develop their pipeline, Prime is working with Beam Therapeutics to enhance therapeutic delivery and manufacturing.
Co-op: Small Scale Guide RNA ChemistryCo-op: Small Scale Guide RNA C...
Cambridge, MA|2 days ago
Co-op: Platform Technologies & InnovationCo-op: Platform Technologies &...
Cambridge, MA|5 days ago
Co-op: Clinical Development - Patient Advocacy and...Co-op: Clinical Development - ...
Cambridge, MA|5 days ago
Co-op: Off-Target Analysis of Gene EditingCo-op: Off-Target Analysis of ...
Cambridge, MA|7 days ago
Sr Scientist, Analytical DevelopmentSr Scientist, Analytical Devel...
Cambridge, MA|16 days ago
Senior Laboratory Operations Associate Senior Laboratory Operations A...
Watertown, MA|16 days ago
Senior Associate Engineer II, Supply Chain & Exter...Senior Associate Engineer II, ...
Watertown, MA|65 days ago
Director, Quality Assurance – Clinical and Nonclin...Director, Quality Assurance – ...
Watertown, MA|100+ days ago
© 2026 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com